Nearly all cervical cancers are causally associated with Human Papillomavirus (HPV). The burden of HPV-associated dysplasias in Sub-Saharan Africa is influenced by HIV. To investigate the role of the bacterial microbiome in cervical dysplasia, cytobrush samples were collected directly from cervical lesions of 144 Tanzanian women. The V4 hypervariable region of the 16S rRNA gene was amplified and deep-sequenced. Alpha diversity metrics; Chao1, PD whole tree, and operational taxonomic Unit (OTU) estimates, displayed significantly higher bacterial richness in HIV positive patients (P = 0.01) than in HIV negative patients. Within HIV positive patients, there was higher bacterial richness in patients with high grade squamous intraepithelial lesions (HSIL; P = 0.13) than those without lesions. The most abundant OTUs associated with high-grade squamous intraepitheilal lesions (HSIL) were Mycoplasmatales, Pseudomonadales, and Staphylococcus. We suggest that a chronic mycoplasma infection of the cervix can contribute to HPV-dependent dysplasia by sustained inflammatory signals.
K l e i n e t a l A b s t r a c t K l e i n e t a l individuals with less than 200 CD4+ cells per μ l serum [7] [8] [9] [10] . Thus, the cervical immune microenvironment may be a co-factor in suppression of cervical cancer. Changes in the cervicovaginal bacterial microbiome has been suggested to contribute to the development of pre-cancerous cervical lesions [11] [12] [13] [14] [15] [16] [17] . Chronic inflammation of the cervix (cervicitis) which is a result of cervicovaginal pathogens, leads to conditions like Pelvic Inflammatory Disease (PID) and Bacterial Vaginosis (BV), both of which are associated with persistent HPV infection and cervical cancer [18, 19] . Both PID and BV are more prevalent in Sub-Saharan Africa and in HIV positive populations [20] [21] [22] . Comparative genomic analyses in women infected with HIV have shown that a shift in microbial diversity as a result of BV is detectable; if this shift directly effects formation of pre-cancerous cervical lesions is not clear [23] . Given that cervical cancer rates which are expected to rise in Sub-Saharan Africa as the HIV positive population receives lifeextending ART, it is even more important to understand the risk factors associated with the cervical microbiome. There are currently no studies that define how cervical microbiota differ at different stages of cervical cytology or as a function of HIV status. The current study defines bacterial communities associated with cervical lesions and with HIV, which represents a significant advance. Cervical cytology is graded by pap smear screening for nuclear abnormalities. There are five stages: negative for intraepithelial lesion or malignancy (NILM), atypical squamous cells of undetermined significance (ASC-US), low-grade squamous intraepithelial lesions (LSIL), atypical squamous cells: cannot exclude high-grade lesions (ASC-H), and high-grade squamous intraepithelial lesions (HSIL) . In this study, we utilized 16s rRNA gene deep-sequencing on a set of 144 cervical swab samples from a cohort of Tanzanian women to gain an understanding of the differences in the cervical bacterial community composition as a function of cervical cytology grade and HIV status. The data presented here identifies bacterial taxonomies associated with high-grade cervical lesions with a new level of precision since swab samples samples were take directly from cervical lesions. The rationale K l e i n e t a l behind this approach was that the sight of the lesion is where tumors form, thus it bacteria associated at this sight were more likely to be relevant to disease status.
Methods

Participants and Ethical Precautions
This study reports findings derived from a larger cross-sectional cohort study analyzing demographics of HPV and cervical cancer in HIV positive and negative women from rural and urban Tanzania. All human subjects protocols were approved by safety committees at Ocean Road Cancer Institute (ORCI) and the University of Nebraska-Lincoln in accordance with the Helsinki Declaration. Participation by patients was entirely voluntary and written patient consent was required for inclusion in the study.
Tanzania is part of an ongoing study site to follow HIV and associated secondary viral infections in women at ORCI, the only cancer treatment hospital in Tanzania. Between March 2015 and February 2016, female patients undergoing cervical cancer screening were approached for enrollment in the study. Those who were pregnant, menstruating, under 18, reported being sick in the past 30 days, or had a preexisting, non-HIV, immunologic defect were excluded from the study. Disease histories as well as physical examinations were carried out to rule out any clinical symptoms or visible signs for these conditions. Samples were collected at three sites:
ORCI in Dar es Salaam, and rural clinics in Chalinze and Bagamoyo. A total of 144 cervical cytobrush samples obtained from these women were sequenced, of which 138 produced at least 1000 reads, and 132 included successful measurements of both HIV status and cervical cytology.
K l e i n e t a l assigned to the OTUs using the assign_taxonomy.py command available in QIIME using the latest version of the Greengenes database (May 2013).
Statistical Analyses
The OTU 
Ethics Statement
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Results
Demographics
Of the 144 patient samples sequenced, 41 were HIV+ and 103 HIV-, with an average age of 37 years old. Cervical cytology was measured to be NILM in 23 samples, LSIL in 72 samples, and HSIL in 50 samples. Visual inspection with acetic acid (VIA), the standard for cervical lesion detection in Tanzania, was carried out immediately following sample collection. Twenty-six patients were found to be VIA positive for cervical lesions and 115 VIA negative. All VIA positive samples were identified as LSIL or HSIL, while several VIA negative samples were found to be NILM, LSIL or HSIL by pap smear. Odds ratios were used to identify risk factors for testing VIA positive. Testing HIV+, HSIL, having >5 sexual partners, and having been infected with a sexually transmitted infection (STI), were identified as risk factors for positive VIA status (p=0.0001, p=0.038, p=0.006, p=0.0008 respectively).
Cervical Bacteria Composition and Richness
K l e i n e t a l Samples rarefied to an even depth (1000 reads) were used to generate 813 OTUs. To assess if the sampling depth was adequate, rarefaction curves were generated using observed OTUs for HIV status and cervical cytology ( Figure S1 ). Rarefaction curves for both did not converge, but showed a diminishing rate of new OTU identification as the number of reads per sample increased, implying that sampling depth was adequate for evaluating dominant members of the cervical bacterial community. The Good's coverage test showed the sequencing depth was able to characterize 99.4% of the bacterial community on average.
The taxonomic analysis of the reads revealed the presence of 6 main phyla (relative abundance >1%) in the cervical epithelium, regardless of HIV or cervical cytology status ( Figure 1 ). 
Cervical Bacterial Diversity Estimates
Alpha diversity metrics, Chao1, observed OTUs, and PD Whole Tree, displayed higher (p = 0.009) bacterial richness in HIV+ compared to HIV-patients ( Figure 3 ). A subset of these samples were matched such that the HIV-and HIV+ groups consisted of the same number of samples, with the same average age, and the same contribution of each cervical cytology to help to control for effects of these confounding variables, and ensure differences in diversity estimates are not due to differences in sample size. In this matched subset, estimates also displayed higher (p = 0.003) bacterial richness in HIV+ patients.
Alpha diversity metrics were similar (P > 0.50) for the samples from patients at different cervical cytology grades (NILM, LSIL, or HSIL) in both matched and unmatched sets. When alpha diversity metrics were compared between cervical cytology groups separately for HIV+ samples, LSIL and HSIL trended towards a higher diversity compared to NILM (p=0.198, p=0.261 respectively). Analysis of age matched, HIV+ NILM/HSIL pairs maintained this trend (p=0.264, Chao1 p=0.13). Comparison of the relative abundance of Genus-level reads between these groups showed a noticeably more diverse profile for HSIL samples, which lack the dominance of Lactobacillus and Haemophilus seen in NILM samples.
Beta diversity analysis showed that bacterial communities were quite varied between samples ( Figure 4 ), no discreet communities characterized a large number of samples. On average, HIV K l e i n e t a l positive patients were shown to have significantly different cervical bacterial communities from HIV negative patients (p=0.001). Similarly, patients who tested positive for HPV tended to have different bacterial communities from those who tested negative (p=0.008). Bacterial communities were also shown to differ significantly depending on cervical cytology among HIV positive patients (p=0.05).
Bacteria Associated with Cervical Cytology States and/or HIV Status
Linear discriminant analysis Effect Size (LEfSe) was used to identify bacterial taxonomies which differentiate cervical microbiota in normal individuals (NILM) from microbiota in patients with pre-cancerous lesions (HSIL). The sum of reads at each taxonomic rank was considered. (Figure 5c ).
An abundance of non-Lactobacillus Bacilli was the most significant differentiating taxonomy between HIV positive and negative samples. Mycoplasma was also associated with HIV+ individuals, supporting the significant difference in relative abundance between HIV positive and negative groups shown previously using a direct Kruskal Wallace comparison. Interestingly, Ureaplasma (a member of Mycoplasmatales) and Lactobacillus reuteri were associated with HIV-patients, while other members of their respective families were associated with HIV+ K l e i n e t a l patients. This suggests the existence of metabolic niches in the cervical microbiome which may be populated by pathogenic or non-pathogenic associating bacteria.
Discussion
It is well established that certain members of the cervicovaginal microbiome protect against Infection with M. genitalium increases the rate of infection with an HPV genotype associated with a high-risk of developing cervical cancer [35] . Recent work has shown that mycoplasma also increases the risk of development of cervical lesions, supporting the association we report Mycoplasma is a low-abundance microbe which has been shown to cause cervicitis. However, the lack of significant associations in previous metagenomic studies, is largely due to a lack of optimization of statistical analyses for the presence of low abundance microbes. In our study,
Mycoplasma was a prominent result, likely due to the large HIV positive proportion of the cohort, wherein immunosuppression allowed higher abundance of the bacteria to accumulate.
Statistical analysis of just the HIV negative portion of the cohort did not identify
Mycoplasmatales as a significant factor. However, a linear increase in the abundance of Mycoplasmatales from NILM to HSIL seen in both HIV positive and negative groups.
Analysis of HIV negative, NILM samples showed an abundance of anaerobic bacteria. This may be a result of the sampling method used, rather than a representation of the average HIV negative NILM cervical microbiome in Tanzania. Because samples were only obtained from women attending the women's clinic, it is possible that some of the women had slightly unusual microbiota due to bacterial infections, but were NILM by the pap smear. If this were the case, it would explain the high contribution of anaerobic and/or pathogenic bacteria in NILM women attending the clinic. Another possibility is that cervicovaginal infection with anaeroabic bacterial in the general population is higher than previoiusly thought.
K l e i n e t a l
In this study, we took great effort to control for variation in the cervical microbiome so as to reduce confounding effects that might obsure the bacterial communities which were associated with HPV pathogenesis. The HIV positive population is of particular interest, since they appear to show enhanced cervical microbiota associated with HPV pathegenesis. In future studies, Because progression of HPV infection to cervical cancer is a process that takes decades, and in many individuals never reaches cancer at all, such a study would need to be large. Studies of the cervical microbiome can be further improved using metagenomic sequencing, rather than 16s or other targeted sequencing techniques which lack depth. 16s amplification ignores microbes which lack a gene to match the primers, for example; viruses, archaea, and eukaryotes are not accounted for. Because only a portion of one gene is being sequenced, the microbes present may only be estimated at the genus level or worse. Since the majority of medium or large scale cervicovaginal microbiome studies have used this method, the role of non-bacterial components of cervicovaginal microbiome in HPV infection and disease has not been characterized.
As the world's HIV positive population grows, cervical cancer is expected to become an even more significant problem, despite increasing coverage of anti-retroviral treatment (ART).
Compared to the risk reduction after ART seen in other AIDS-defining cancers like Kaposi's sarcoma and non-Hodgkin's lymphoma, the risk of cervical cancer is not significantly affected, and recurrence rates remain high with or without treatment [37] [38] [39] [40] . Studies in this area suggests that progression of HPV infection depends on immunological status of the host such that ART is only able to indirectly affect HPV pathogenesis, potentially through an effect on circulatory CD4+ cell count. Identifying which aspects of the local and systemic effects of HIV infection contribute to progression from latent HPV infection to cervical cancer is crucial to understanding and predicting HPV pathogenesis. Current knowledge suggests effects on the cervical immune microenvironment may be key in this process. Understanding microbes which influence this environment will help identify cervical microbiota associated with low and highgrade cervical lesions. This may allow certain cervical microbiota to be used as diagnostic markers for those at high risk of developing cervical cancer, and for the development of preventative probiotic or antibiotic treatments which could control the cervical microbiome by promoting bacterial colonization with a microbiota associated with healthy cervical cytology.
Our studies have identified a unique microbiota associated with HSIL. Data derived from of our precise sampling of cervical lesions leads us to propose that Mycoplasma contributes to a cervical microbiome status which promotes HPV-related cervical lesions. These results suggest a greater influence of the bacterial microbiota on the outcome of HPV infection than previously thought. Figure S1 : Bacterial 16s deep sequencing data was analyzed with rarefaction curves generated from the OTU data. These rarefactions were then compared with HIV status and cervical cytology. S1A. The red square represents HIV negative: "0," and the black square represents HIV positive: "1." The line indicated as "NA" is the unadjusted control. S1B. The red square represents HSIL , and the blue square represents LSIL. The green square represents NILM. The line indicated as "NA" is the unadjusted control. M  u  n  g  o  C  ,  C  o  h  e  n  C  R  ,  M  a  l  o  b  a  M  ,  B  u  k  u  s  i  E  A  ,  H  u  c  h  k  o  M  J  .  P  r  e  v  a  l  e  n  c  e  ,  c  h  a  r  a  c  t  e  r  i  s  t  i  c  s  ,  a  n  d  o  u  t  c  o  m  e  s  o  f  H  I  V  -p  o  s  i  t  i  v  e  w  o  m  e  n  d  i  a  g  n  o  s  e  d  w  i  t  h  i  n  v  a  s  i  v  e  c  a  n  c  e  r  o  f  t  h  e  c  e  r  v  i  x  i  n  K  e  n  y  a  .  I  n  t  J  G  y  n  a  e  c  o  l  O  b  s  t  e  t  .  2  0  1  3  ;  1  2  3  (  3  )  :  2  3  1  -5  .  E  p  u  b  2  0  1  3  /  1  0  /  0  8  .  d  o  i  :  1  0  .  1  0  1  6  /  j  .  i  j  g  o  .  2  0  1  3  .  0  7  .  0  1  0  .  P  u  b  M  e  d  P  M  I  D  :  2  4  0  9  5  3  0  8  ;  P  u  b  M  e  d  C  e  n  t  r  a  l  P  M  C  I  D  :  P  M  C  P  m  c  4  1  5  1  4  6 
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